IP Library Assignment 033212/0635
Patent Assignment
Reel/Frame 033212/0635

Change of Name

Recorded: 2014-06-19 Pages: 2
Assignor
EURAND, INCORPORATED
Executed: 2011-07-12
Assignee
APTALIS PHARMATECH, INC.
845 CENTER DRIVE, VANDALIA, OHIO, 45377
Covered Property (1)
Orally disintegrating tablets and methods of manufacture
Patent: 8,545,881 →
Application: 10/827,106 →
Publication: US 2005/0232988
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Sep 4, 2015
From: EURAND PHARMACEUTICALS LTD.
To: APTALIS PHARMA LIMITED
Reel/Frame 036554/0819 →
Assignment of Assignor's Interest Sep 4, 2015
From: APTALIS PHARMA LIMITED
To: APTALIS PHARMATECH, INC.
Reel/Frame 036495/0555 →
Change of Name Sep 4, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036554/0829 →
U.S. Patent Security Agreement Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276 Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Security Interest Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →